Acuitas Lipid III-7 |DC Chemicals

Cas No.:
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Publication:	US 10,166,298 B2.

MSDS

Cat. No.	Product name	Field of application
DC67218	Moderna Lipid compound 182	Moderna Lipid compound 182 is an novel ionizable amine lipid used for mRNA delivery from Moderna patent WO2017049245A2
DC67217	Moderna Lipid compound 46	Moderna Lipid compound 46 is an novel ionizable amine lipid used for mRNA delivery from Moderna patent WO2017049245A2
DC67215	Acuitas Lipid III-7	Acuitas Lipid III-7 is an novel ionizable amine lipid used for mRNA delivery from Acuitas Therapeutics patent US 10,166,298 B2.
DC67214	Acuitas II-12	Acuitas II-12 is an novel ionizable amine lipid used for mRNA delivery from Acuitas Therapeutics patent WO2016176330A1
DC67213	Acuitas II-10	Acuitas II-10 is an novel ionizable amine lipid used for mRNA delivery from Acuitas Therapeutics patent WO2016176330A1
DC60711	CL15F 9-5	CL15F 9-5 is a piperidine-based ionizable lipid for mRNA delivery and improves the long-term storage stability of mRNA/LNPs at refrigeration temperature as a liquid formulation. CL15F 9-5 LNPs exhibits significantly stronger antigen-specific cellular responses than mice immunized with SM-102 and ALC-0315 LNPs.